[ Price : $8.95]
FDA approves a PTC Therapeutics NDA for Sephience (sepiapterin), indicated for treating adult and pediatric patients with phenylke...[ Price : $8.95]
FDA posts the user fee rates for fiscal year 2026 for prescription drugs and biologics, biosimilar, medical devices and generic dr...[ Price : $8.95]
Recognify Life Sciences says its Phase 2b trial of inidascamine, a drug candidate for treating cognitive impairment associated wit...[ Price : $8.95]
After being criticized for attempting to bypass a formal advisory committee review of warnings associated with hormone replacement...[ Price : $8.95]
FDA issues a revised draft guidance entitled Small Volume Parenteral (SVP) Drug Products and Pharmacy Bulk Packages for Parenteral...[ Price : $8.95]
FDA investigates another death of a young boy who received Sarepta Therapeutics gene therapy Elevidys for Duchenne muscular dystro...[ Price : $8.95]
Roche announces new data on its Alzheimers therapy trontinemab and its plans to begin two Phase 3 clinical trials by the end of th...[ Price : $8.95]
Bipartisan House lawmakers urge FDA to block counterfeit anti-obesity medications entering the U.S.